Sulforaphane for Detoxification

Research suggests that sulforaphane supports detoxification primarily by activating the Nrf2 signaling pathway, which upregulates a broad network of phase II detoxification enzymes, antioxidant defenses, and cellular protective responses — a mechanism consistently highlighted across multiple reviews and preclinical studies. Studies indicate that sulforaphane is notably more potent at activating Nrf2 than other commonly studied plant compounds such as curcumin and resveratrol, and a 2025 review of 84 registered clinical trials found published human evidence suggesting it can enhance detoxification and reduce inflammation, though roughly half of completed trials remain unpublished, raising concerns about publication bias. The body of evidence is largely drawn from reviews of preclinical and mechanistic research, with far fewer rigorous human trials, and findings are complicated by the fact that sulforaphane interacts with both phase I and phase II metabolic enzymes in ways that could alter drug bioavailability and, in at least one cell study, paradoxically depleted glutathione reserves in a manner that may have reduced — rather than enhanced — the clearance of a co-occurring dietary toxin. Overall, the evidence is promising but mixed, and researchers consistently call for larger, better-controlled human trials before strong conclusions about sulforaphane's detoxification benefits in clinical settings can be drawn.